Back to search

University of Minnesota

Combining Energy-based Focal Therapy and Immunotherapy for Improved Primary and Systemic Cancer Control

Abstract

dc:description.abstract

Energy-based focal therapy (FT), or ablation therapy, including thermal therapy (Heat), cryosurgery (Cryo) and irreversible electroporation (IRE), utilizes targeted, minimally invasive procedures to destroy tumors while preserving healthy tissues and function. However, this type of treatment is often limited by local and systemic recurrence. A rapidly growing area of research in energy-based ablation techniques is based on the idea of immunomodulation that is activated by these therapies, as summarized in the first chapter. Although various ablation modalities have been shown to stimulate antitumor immune responses, the extent to which these immunostimulatory effects can be achieved, and the factors that could influence immune priming, have yet to be systematically investigated. To provide an in vitro platform for quantitatively assessing the immunogenic response to cancer cell treatments and to expand our understanding of immune modulation by focal therapy in adaptive immune response, we employed a model antigen (ovalbumin, OVA) to investigate key immunological aspects of FTs, including antigen release, generation of damage-associated molecular patterns (DAMPs), cytokines, and chemokines, antigen presentation, and activation of antigen-specific T cells, with a comparison of different focal treatments. However, it is crucial to recognize that the immune response stimulated by ablation alone is often insufficient to completely eliminate established tumors and metastatic lesions. Therefore, there is a strong emerging interest in combining immunotherapies with ablation to stimulate a more robust antitumor reaction. Among the various types of immunotherapies, immune checkpoint blockade therapy (ICB) has become our focus, given the mechanism of action. Despite the enhanced therapeutic outcomes demonstrated by this combination strategy in the literature, limited research has comparatively investigated diverse ablation techniques in the context of immunotherapy. Thus, we assessed the synergistic effects of various ablation techniques (cryoablation, thermal ablation and IRE) with anti-PD-1 ICB immunotherapy in a colorectal cancer model using well-characterized miniature probes. In this model, we evaluated primary tumor growth delay, long-term survival, and protection against secondary tumor challenge. Additionally, we investigated the mechanism behind the synergistic effect through the analysis of intratumoral immune cells and depletion studies. To explore the potential of using temperature as an indicator of response to immunotherapy, we utilized miniaturized battery-free wireless chips to capture both basal and tumor temperature dynamics in various murine tumor models with different treatments. Lastly, we conducted a comprehensive review of current preclinical and clinical studies on the combined therapy of FT and immune checkpoint inhibitors (ICIs). We analyzed the challenges faced and proposed potential future research directions.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jiang, Minhan

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Citation
Jiang, Minhan. (2024). Combining Energy-based Focal Therapy and Immunotherapy for Improved Primary and Systemic Cancer Control. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/280366.

Chain of custody

source
Harvested from
University of Minnesota
Base URL
conservancy.umn.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Jiang, Minhan. Combining Energy-based Focal Therapy and Immunotherapy for Improved Primary and Systemic Cancer Control. 2024. https://hdl.handle.net/11299/280366